Skip to main content
Log in

Stem cell transplantation for thalassemia

  • Asian Cooperation in the Field of Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Thalassemia, one of the most common genetic disorders, is considered to be a global problem. Several millions of the patients suffer from severe thalassemic diseases. Stem cell transplantation is currently the only curative therapy. Bone marrow transplantation offers a high probability of cure when performed in young children. There is a higher risk as the patient becomes older, especially the high incidence of graft rejection. Modified conditioning regimens have been developed to overcome graft rejection in patients with class III or full blown manifestations. The alternative use of stem cell from cord blood makes possible earlier transplant with better chance of cure, although the engraftment is slower compared to bone marrow transplantation. More experiences with regard to stem cell transplantation in adult patients, the use of stem cell transplantation from related donors as well as matched unrelated donors are necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chernoff AI. The distribution of the thalassemia gene. A historical review.Blood. 1959;14:899.

    PubMed  CAS  Google Scholar 

  2. Weatherall DJ. Thalassemia in the next millennium.Ann NY Acad Sci. 1998;850:1–9.

    Article  PubMed  CAS  Google Scholar 

  3. Wasi P. Haemoglobinopathies including thalassemia. Part 1.Tropical Asia. Clin Haematol. 1981;10:702–729.

    Google Scholar 

  4. Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E β-thalassemia.Cur Opin Hematol. 2000;7:106–112.

    Article  CAS  Google Scholar 

  5. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia.N Engl J Med. 1990;322:417–421.

    PubMed  CAS  Google Scholar 

  6. Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients.Blood. 1996;87:2082–2088.

    PubMed  CAS  Google Scholar 

  7. Angelucci E, Lucarelli G. Bone marrow transplantation in β-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL (eds). Disorders of Hemoglobin: Geneties, Pathophysiology and Clinical Management, pp 1052–1072. Cambridge: Cambridge University Press, 2001.

    Google Scholar 

  8. Issaragrisil S, Suvatte V, Visudhisakchai S, et al. Bone marrow and cord blood stem cell transplantation for thalassemia in Thailand.Bone Marrow Transplant. 1997;19(Suppl 2):54–56.

    Google Scholar 

  9. Sodani P, Gaziev D, Erer B, et al. New preparative regimen for bone marrow transplantation in Class 3 young and adult thalassemic patients.Bone Marrow Transplant. 2002;29(Suppl 2).

  10. Barbanti I, Muretto P. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassemia.Brit J Haematol. 1995;89:868–873.

    Google Scholar 

  11. Angelucci E, Ripalti M, Baronchiani D, et al Phlebotomy to reduce iron overload in patients cured of thalassemia by marrow transplantation.Bone Marrow Transplant. 1997;19 (Suppl 2):123–125.

    Google Scholar 

  12. Gaziev J, Galimberti M, Giardini C, et al. Growth in children after bone marrow transplantation for thalassemia.Bone Marrow Transplant. 1993;12(Suppl 3):100–101.

    PubMed  Google Scholar 

  13. de Sanctis V, Galimberti M, Lucarelli G, et al. Growth and development in ex-thalassemia patients.Bone Marrow Transplant. 1997;19(Suppl 2):48–53.

    Google Scholar 

  14. de Sanctis V, Galimberti M, Lucarelli G, et al. Gonadal function after allogeneic bone marrow transplantation for thalassemia.Arch Dis Child. 1991;66:517–521.

    Article  PubMed  Google Scholar 

  15. de Simone M, Oloioso P, di Bartolomeo P, et al. Growth and endocrine function following bone marrow transplantation for thalassemia.Bone Marrow Transplant. 1995;15:227–233.

    PubMed  Google Scholar 

  16. Lucarelli G, Clift RA, Galimberti M, et al. Bone marrow transplantation in adult thalassemia patients.Blood. 1999;93:1164–1167.

    PubMed  CAS  Google Scholar 

  17. Gaziev D, Galimberti M, Luccuelli G, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants.Bone Marrow Transplant. 2000;25:815–821.

    Article  PubMed  CAS  Google Scholar 

  18. La Nasa G, Giardini C, Locatelli F, et al. Unrelated donor bone marrow transplantation for thalassemia (preliminary report).Blood. 2000;96(Suppl 1):414a.

    Google Scholar 

  19. Issaragrisil S, Visuthisakchai S, Suvatte V, et al. Transplantation of cord blood stem celll into a patient with severe thalassemia.N Engl J Med. 1995;332:367–369.

    Article  PubMed  CAS  Google Scholar 

  20. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.Blood. 1998;91:756–763.

    PubMed  CAS  Google Scholar 

  21. Aker M, Kapelushnik J, Pugatsch T, et al. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.J Ped Hematol Oncol. 1998;20:145–148.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Issaragrisil, S. Stem cell transplantation for thalassemia. Int J Hematol 76 (Suppl 1), 307–309 (2002). https://doi.org/10.1007/BF03165269

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03165269

Keywords

Navigation